Compare Davita Inc (DVA) vs Wendys Co (WEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Wendys Co — how do they compare? Davita Inc trades at $178.34 (market cap $11.72B), while Wendys Co trades at $7.53 (market cap $1.39B). The key difference: Davita Inc is far larger — about 8.4× Wendys Co's market cap, and Wendys Co pays a 3.84% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | WEN | |
|---|---|---|
Market Cap | $11.72B | $1.39B |
Sector | Health | Consumer Cyclical |
52-Week High | $240.96 | $10.68 |
52-Week Low | $103.87 | $6.17 |
Enterprise Value | $24.44B | $5.12B |
Dividend Yield | — | 3.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Wendy's stock (WEN) trades at $7.69, up 4.06% in the last session, with a bullish technical signal from moving averages and a consensus price target of $9.33. Recent Q2 2026 EPS beat estimates at $0.18, but revenue trends show stagnation near $2.2B, with net income declining to $165M in 2025. The company faces headwinds from a dividend cut and lost market share to Burger King, as new leadership pursues a turnaround plan amid weak U.S. traffic.
The outlook is cautious; valuation ratios like P/E of 11.67 and P/S of 0.67 suggest undervaluation, but high debt and competitive pressures pose risks. Analyst sentiment is mixed with 62.75% hold ratings, reflecting uncertainty over the turnaround's success. Near-term performance hinges on execution of strategic initiatives to revive sales and margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Wendys Co
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →
